Citation Impact
Citing Papers
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Yersinia pseudotuberculosis Effector YopJ Subverts the Nod2/RICK/TAK1 Pathway and Activates Caspase-1 to Induce Intestinal Barrier Dysfunction
2012
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Gastric cancer
2016 Standout
Wheatgerm agglutinin-mediated toxicity in pancreatic cancer cells
1999
Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen
1999
Maintenance treatment of Crohn's disease
2003
Base-excision repair of oxidative DNA damage
2007 StandoutNature
Management of Crohn's disease in adults
2001
Characterization of the Gastrointestinal Microbiota in Health and Inflammatory Bowel Disease
2011
Delayed graft function in kidney transplantation
2004 Standout
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
2002 Standout
5-Aminosalicylates Prevent Relapse of Crohn's Disease After Surgically Induced Remission: Systematic Review and Meta-Analysis
2010
Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction
2001 Standout
Ulcerative Colitis
2011 Standout
Long-term outcome 10 years or more after restorative proctocolectomy and ileal pouch–anal anastomosis in patients with ulcerative colitis
2009
Roles of cPLA2α and arachidonic acid in cancer
2006
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
2006 StandoutNature
A microRNA component of the p53 tumour suppressor network
2007 StandoutNature
Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study
2001
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Crohn's disease
2012 Standout
Genomic instability in Ip and human malignancies
1996
Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease
2003
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Severe Sepsis and Septic Shock
2013 Standout
The multiple colorectal adenoma phenotype and MYH, a base excision repair gene
2004
Inflammatory Bowel Disease
2009 Standout
Acute Pancreatitis
2016 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Global cancer statistics
2011 Standout
Objective Estimates of the Probability of Death from Burn Injuries
1998 Standout
Ulcerative colitis
2012 Standout
Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: A randomized, double-blind, placebo-controlled trial
2005
10 Adjuvant post-operative therapy
1998
Genomic structure and loss of heterozygosity of EPHB2 in colorectal cancer
2001
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
2007 Standout
Crohn's disease
2016 Standout
Inflammatory Bowel Disease
2002 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Postburn Pancreatitis
1995
Acute Gastroenteritis Is Followed by an Increased Risk of Inflammatory Bowel Disease
2006
Preventing Postoperative Recurrence in Crohn’s Disease: What Does the Future Hold?
2013
Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials
2000
Management of the patient with progressive radioiodine non-responsive disease
1999
Results and Complications after Ileal Pouch Anal Anastomosis: A Meta-Analysis of 43 Observational Studies Comprising 9,317 Patients
2005
Hereditary Colorectal Cancer
2003 Standout
Ulcerative colitis
2016 Standout
Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection
2008
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Detection of SYT–SSX1/2 fusion transcripts by reverse transcriptase–polymerase chain reaction (RT–PCR) is a valuable diagnostic tool in synovial sarcoma
1998
Acute Pancreatitis
1994 Standout
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
2012 Standout
Gastric cancer
2020 Standout
Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials
1999
Assessment of renal graft function by perioperative monitoring of cortical microcirculation in kidney transplantation.1
2003
Multiple Colorectal Adenomas, Classic Adenomatous Polyposis, and Germ-Line Mutations inMYH
2003
CHD5 Is a Tumor Suppressor at Human 1p36
2007
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Surgery for Inflammatory Bowel Diseases
2003
Fluid Resuscitation in Acute Pancreatitis
2008
A Conditional Mouse Model of Synovial Sarcoma: Insights into a Myogenic Origin
2007 StandoutNobel
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Management of Crohn's Disease in Adults
2009 Standout
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease
2004
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Value of Tumor Markers in Colorectal Cancer
1998
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
Low-level microsatellite instability in most colorectal carcinomas.
2002
Deficiencies in Mouse Myh and Ogg1 Result in Tumor Predisposition and G to T Mutations in Codon 12 of the K-Ras Oncogene in Lung Tumors
2004 StandoutNobel
Benefit of operative mortality reduction on colorectal cancer survival
2002
Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer
2010
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2016
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
2003 Standout
Hypoxia-inducible factor plays a gut-injurious role in intestinal ischemia reperfusion injury
2010 StandoutNobel
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma
1999 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Imaging the glycome
2008 StandoutNobel
Bile Acid Regulation of C/EBPβ, CREB, and c-Jun Function, via the Extracellular Signal-Regulated Kinase and c-Jun NH2-Terminal Kinase Pathways, Modulates the Apoptotic Response of Hepatocytes
2003
The ecology of the microbiome: Networks, competition, and stability
2015 StandoutScience
European evidence-based Consensus on the management of ulcerative colitis: Current management
2008
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Stress Ulcer Prophylaxis in Critically III Patients
1996
Accumulation of the Oxidative Base Lesion 8-Hydroxyguanine in DNA of Tumor-Prone Mice Defective in Both the Myh and Ogg1 DNA Glycosylases
2004 StandoutNobel
Thyroid carcinoma
2003 Standout
Works of C Herfarth being referenced
Postoperative Recurrence of Crohn’s Disease in Relation to Radicality of Operation and Sulfasalazine Prophylaxis: A Multicenter Trial
1989
Impairment of hepatic microcirculation as an early manifestation of acute rejection after clinical liver transplantation
1999
Continuous Measurement of Porcine Renal Cortex Microcirculation with Enhanced Thermal Diffusion Technology
1996
Extrahepatic biliary obstruction impairs microvascular perfusion and increases leukocyte adhesion in rat liver
1997
NF-κB antisense oligonucleotides reduce leukocyte-endothelial interaction in hepatic ischemia-reperfusion
2001
Prä- und postoperative Lebensqualität von Patienten mit Colitis ulcerosa und familiärer adenomatöser Polyposis bei ileoanaler Pouchoperation
1998
Molecular profiling of sporadic colorectal tumors by microsatellite analysis.
2000
[Technique and results of the ileoanal pouch after proctocolectomy].
1994
Prevalence of enteropathogenic bacteria in surgically treated chronic inflammatory bowel disease.
1999
Analysis of FUS-CHOP fusion transcripts in different types of soft tissue liposarcoma and their diagnostic implications.
1998
Somatostatin analog octreotide inhibits the growth of differentiated thyroid cancer cells in vitro, but not in vivo.
1996
Outcome after emergency surgery for cancer of the large intestine
1991
[Stress-ulcer prevention with pirenzepine-a controlled study].
1980
Pancreatic ischaemia in experimental acute pancreatitis: Mechanism, significance and therapy
1990
Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer.
1995
Re-operation for recurrent colorectal cancer: the importance of early diagnosis for resectability and survival.
1990
Lectins and immunohistochemistry of colorectal cancer, its recurrences and metastases.
1990
Outcome after septic complications in J pouch procedures
2002
Adjuvant 5-Fluorouracil and BCNU Chemotherapy in Gastric Cancer: 3-Year Results
1982